Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Consolidated Net Income (2009 - 2026)

Updated

Sanofi's Consolidated Net Income came in at $438.21 million for the quarter ended Jun 30, 2026, down 94.0% from $7.31 billion a year earlier and down 76.9% from the prior quarter.

Analysis

Sanofi (SNY) Consolidated Net Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sanofi reported Consolidated Net Income of $2.37 billion, down 81.7% year-over-year; for the year ended Dec 31, 2025, it came in at $8.87 billion, up 45.9% from the prior year.

  • Consolidated Net Income carries a five-year compound annual growth rate of -8.8% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Consolidated Net Income was $6.08 billion in the year ended Dec 31, 2024 (+3.4%), $5.88 billion in the year ended Dec 31, 2023 (-34.2%), $8.94 billion in the year ended Dec 31, 2022 (+20.3%) and $7.43 billion in the year ended Dec 31, 2021 (-47.2%).
  • The five-year range for quarterly Consolidated Net Income is -$10.07 billion (the quarter ended Dec 31, 2025) to $10.11 billion (the quarter ended Sep 30, 2025).
  • Year-over-year, Consolidated Net Income increased in three of the last seven quarters, with growth averaging 80.8%.
  • The fastest year-over-year change in Consolidated Net Income over five years came in the quarter ended Jun 30, 2025 (growth of 507.7%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 94.4%).
  • Business Quant data shows SNY's Consolidated Net Income at $1.9 billion (quarter ended Mar 31, 2026), -$10.07 billion (quarter ended Dec 31, 2025) and $10.11 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 210.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 3.62 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 2.51 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -237.00 Mn
10 Sanofi 50.63 Bn 17.15 Bn 10.79 Bn 438.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 438.21 Mn
Mar 31, 2026 1.90 Bn
Dec 31, 2025 -7.72 Bn
Sep 30, 2025 10.11 Bn
Jun 30, 2025 4.46 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 546.05 Mn
Sep 30, 2024 3.12 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.24 Bn
Dec 31, 2023 -600.37 Mn
Sep 30, 2023 2.76 Bn
Jun 30, 2023 1.58 Bn
Mar 31, 2023 2.16 Bn
Dec 31, 2022 3.23 Bn
Sep 30, 2022 2.10 Bn
Jun 30, 2022 1.30 Bn
Mar 31, 2022 2.26 Bn
Dec 31, 2021 1.31 Bn
Sep 30, 2021 2.75 Bn
API Access

Sanofi Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=SNY&period=max&api_key=YOUR_API_KEY